Foreign Direct Investment approvals: Government cleared multiple sectoral proposals including equity restructurings and post facto regularisations.
Government action on FDI: the Government authorised a set of inbound investment proposals across defence, telecom, pharma, NBFCs, insurance and investing companies, permitting foreign equity increases, downstream investments, formation of wholly owned subsidiaries, and post facto regularisations of prior foreign investments, while deferring and rejecting separate proposals and advising that FIPB approval was not required in two instances.

Tax administration IT reform: centralise national processing and analytics to improve taxpayer services and risk targeting.
The report proposes centralising tax administration functions into national units-including a National Taxpayer Services Directorate, National Assessment Centre for Customs and a National Processing Centre for returns-and creating specialised function based units for Data Analytics, Dispute Resolution and BPR, while recommending merging customs IT into a single system, adopting Service Oriented Architecture, enabling mobility, introducing entity based risk management and implementing IT centric HR policies, with actions sequenced as short, medium and long term under a governance oversight framework.

Restricted import of fireworks bars illegal foreign pyrotechnics with hazardous chemicals; report possession or sale for enforcement.
Fireworks of foreign origin are restricted import items and explosives containing sulphur-chlorate mixtures are prohibited; no import licences have been issued under the explosives regulatory framework. Reports show smuggling of fireworks containing the hazardous chemical potassium chlorate into retail channels, and the public is requested to report possession or sale to police or district authorities for enforcement.

Trade deficit rises sharply as imports outpace exports, driven by surges in gold and mineral imports.
Merchandise exports recorded modest dollar term growth for September 2014 and cumulatively for April-September 2014-15, while imports rose substantially in September producing a markedly larger monthly trade deficit; the September deficit is mainly due to imports rising faster than exports, led by exceptional increases in gold imports and large growth in metalliferous ores and other minerals. Oil imports rose year on year, non oil imports increased sharply for the month, and services trade for August 2014 showed a positive net export balance.

Foreign direct investment approvals and routing decisions issued, including approvals, deferrals, rejection and CCEA referral.
Twenty-five FDI proposals across sectors such as pharma, single-brand retail trading, print media, telecom and defence were approved by the Board, covering equity infusion, incorporation of wholly owned subsidiaries, stake acquisitions and post-facto regularisations. One large pharma proposal was recommended to the Cabinet Committee on Economic Affairs for consideration. Two proposals were deferred and one was rejected. Administrative advice was issued identifying one proposal as falling under the automatic route, one as not within the Board's remit, and one as partly automatic with remaining elements outside FDI.

Indirect tax revenue provisional collections through September show mixed growth across customs, excise and service tax and lower BE attainment.
Provisional indirect tax collections for April-September 2014 compare month wise and cumulatively with the prior year, showing mixed monthly growth across Customs, Central Excise and Service Tax but overall cumulative receipts below the Budget Estimate; Central Excise totals exclude cess administered by other departments.

Government support for pharmaceutical trade boost: Brand India Pharma showcases responsible healthcare and expands global industry engagement.
The Department of Commerce and IBEF coordinated a Brand India Pharma presence at CPhI Worldwide 2014, inaugurating a large India Pavilion with senior commerce and regulatory officials to promote Indian pharmaceutical engagement. The campaign emphasised accessible, affordable healthcare and a national message of responsible healthcare, with major companies adopting the Rx India Responsible Healthcare motif. IBEF arranged high-level media and industry interactions and pre-congress sessions to increase global awareness of India's pharmaceutical capabilities and support export promotion.